Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) to ...

Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ...

HengHong Technology, a holding company incorporated in the Cayman Islands, filed for a 2 million-share initial public offering, saying it intends to apply to list on the Nasdaq Capital Market under ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...

The potential delay in filing has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. The Company plans to file its Form 20-F as soon as practicable; however ...

Focus on developing futuristic products and affordable solutions are the fundamental pillars of India's global leadership in pharmaceuticals and medical technology, said Amit Agrawal, secretary, ...

In trading on Thursday, shares of Arrowhead Pharmaceuticals Inc (Symbol: ARWR) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $14.87 per share.

1 In May 2024, the companies signed a memorandum of understanding to explore the potential for creating an innovative cell therapy ecosystem through the combination of Maholo and pharmaceutical ...

JCR Pharmaceuticals Co., Ltd., together with ... with Modalis Therapeutics Corporation to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming ...